id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2003-D-0031-0012,FDA,FDA-2003-D-0031,Final Guidance for Industry Pharmacogenomic Data Submissions,Other,Guidance,2019-03-14T04:00:00Z,2019,3,2019-03-14T04:00:00Z,,2024-11-12T22:56:15Z,,1,0,0900006483ae1ade
FDA-2003-D-0031-0011,FDA,FDA-2003-D-0031,FDA,Notice,NAD-Notice of Availability of Data,2005-03-29T05:00:00Z,2005,3,2005-03-23T05:00:00Z,2006-03-24T04:59:59Z,2008-04-12T00:54:06Z,,0,0,09000064804815c4
FDA-2003-D-0031-0010,FDA,FDA-2003-D-0031,FDA,Notice,NAL-Notice of Approval,2004-12-28T05:00:00Z,2004,12,2004-12-23T05:00:00Z,,2008-04-12T00:54:06Z,,0,0,09000064804815bc
FDA-2003-D-0031-0009,FDA,FDA-2003-D-0031,Supporting Statement,Supporting & Related Material,SS-Supporting Statement,2004-12-28T05:00:00Z,2004,12,,,2008-04-12T00:54:07Z,,0,0,09000064804815ba
FDA-2003-D-0031-0008,FDA,FDA-2003-D-0031,Supporting Statement,Supporting & Related Material,SS-Supporting Statement,2004-12-28T05:00:00Z,2004,12,,,2008-04-12T00:54:07Z,,0,0,09000064804815b9
FDA-2003-D-0031-0007,FDA,FDA-2003-D-0031,FDA,Notice,N-Notice,2004-08-18T04:00:00Z,2004,8,2004-08-06T04:00:00Z,,2008-04-12T00:54:06Z,,0,0,09000064804815b8
FDA-2003-D-0031-0001,FDA,FDA-2003-D-0031,FDA,Notice,NAD-Notice of Availability of Data,2003-11-04T05:00:00Z,2003,11,2003-11-04T05:00:00Z,2004-01-06T04:59:59Z,2008-04-12T00:54:06Z,,0,0,090000648048155f
FDA-2003-D-0031-0002,FDA,FDA-2003-D-0031,Guidance,Supporting & Related Material,GDL-Guidance,2003-11-04T05:00:00Z,2003,11,,,2008-04-12T00:54:06Z,,0,0,0900006480481562